Abstract
Chronic traumatic encephalopathy (CTE) is a neurodegenerative disease characterized by the presence of abnormally phosphorylated tau protein in the depths of one or more cortical sulci. Controversy over the risk of CTE and neurologic disorders later in life among contact sport athletes has taken hold in the public spotlight, most notably in American football. Players, parents, coaches, and legislators have taken action based on the commonly held notion that contact sports invariably lead to neurodegenerative disorders. However, to fully understand the science behind this assumed association, a critical appraisal of the evidence is warranted. With regards to CTE in sports, the objectives of the current report are to: 1) describe the history of CTE, 2) review current CTE definitions, 3) critically evaluate the empiric data, divided into all contact sports and exclusively American football, and 4) summarize notable themes for future research.
Keywords
INTRODUCTION
Significant public attention has surrounded the topic of chronic traumatic encephalopathy (CTE) and neurodegenerative diseases in athletes exposed to concussive and sub-concussive impacts. Based largely on anecdotal case reports from boxers [1] and convenience samples of football players [2], it has quickly become accepted that repetitive neurotrauma suffered in sport has deleterious effects on long-term brain function. Legal actions against prominent sporting organizations have ensued, [3] and sweeping legislation affecting youth sports has been proposed [4]. Furthermore, widely disseminated and publicized accounts of CTE in prominent former NFL players have portrayed an assumed perception of inevitable later-life cognitive dysfunction in former football players [5]. It is possible that this bias is a result of the availability cascade, [6, 7]where dramatic, individual examples readily available to the public are believed to be the rule, in place of existing empirical data. The availability cascade [6, 7] may have contributed to the departure from a measured, scientific approach to a complex problem.
Though knowledge of CTE has existed in some variant since the 1920s, modern accounts of CTE have brought forth more questions than answers. No accepted clinical criteria exist, and diagnosis can only be made postmortem. Whereas some neurodegenerative diseases have had rigorous clinical and pathologic diagnostic criteria for several years, [8] consensus neuropathologic guidelines for CTE have existed only since 2016.
Forty-three years prior to the consensus guidelines, Corsellis et al. [1] first proposed four neuropathologic criteria necessary for a CTE diagnosis, while the modern criterion relies on a single finding. In the last decade, the two different sets of pathologic criteria that preceded the consensus guidelines, provided by two major research groups, varied considerably [9]. Currently, the hallmark neuropathologic finding is abnormally phosphorylated tau protein (p-tau) accumulation in the depths of one or more cortical sulci, the only overlapping feature among prior proposed criteria.
Controversy over a 90-year-old disease has been reignited. Given the widespread public health implications for all those involved in contact sports, a thorough review of the existing evidence is warranted. The objective of the current report is to: 1) discuss the history of CTE in sports, 2) define previous and current guidelines of CTE, 3) critically review the literature on CTE in contact sports (divided into football and other contact sports), and 4) synthesize these findings to summarize notable themes and directions for future work.
METHODS
In the current narrative review of CTE in sports, studies were identified through an electronic search of the English Literature, using PubMED, Google Scholar, and the Cochrane Database. The following search terms were used: chronic traumatic encephalopathy, CTE, neurodegenerative diseases, professional athletes, concussion, subconcussion, traumatic brain injury, and multiple sports. Abstracts were screened and articles discussing CTE in athletes, spanning the high school to professional level, were reviewed. Any relevant references from the selected literature were searched to ensure a thorough capture. Only human studies published in English were included. Specific studies were selected for in depth discussion of methodological strengths and flaws.
The literature regarding CTE and neurodegenerative disorders in athletes as they relate to psychiatric diagnoses and repetitive head trauma is expansive. For the purposes of this narrative review, we aim to focus on CTE and similar neurodegenerative disorders. While brief mention will be made to associated diagnoses, exclusive discussion of depression [10, 11], suicide [12, 13], and repetitive brain trauma [14] will be limited.
BRIEF HISTORY
Since as far back as Hippocrates (460-370 BCE), humans have been aware of the potential harm of brain injury during sport [15]. The Muslim physician Rhazes (850–923 AD) was the first to use the term “concussion” in the modern sense, identifying it as a transient psychologic state distinct from other severe brain injuries [16]. Throughout the 17th to 19th centuries, various explanations for concussion prevailed, from “molecular vibration” [17] to “nerve cell shock” [18].
Research on concussion in the early 1900s was fueled in part by the severity of injuries incurred in early college football [19, 20]. After the death of a Harvard football player in 1906, team physicians Nichols and Smith (1906) published The Physical Aspect of American Football, [21] a paper that described the types of injuries sustained by members of the Harvard football team, among the most prominent of which was “cerebral concussion.” Nichols and Smith noted that concussions were alarmingly prevalent and treated as a trivial injury, yet there remained the “possibility of serious after effects.” The authors concluded that significant changes to the game would be required to improve player safety [21]. The American Medical Association (AMA) echoed these sentiments in a 1906 editorial, stating that, “Perhaps the most serious feature of these accidents is the number of concussions of the brain reported … At the present time no one is ready to say whether concussion of the brain may or may not have serious consequences in after life” [22].
In 1905, as a response to the growing worry regarding the casualties in amateur football, President Theodore Roosevelt met with leaders from Ivy League schools to identify ways to improve college football safety [23]. Changes were made that reduced the number of collisions, legitimized the forward pass, and ultimately made it easier for officials to intervene in the case of injury [24]. These meetings also established the Intercollegiate Athletic Association of the United States, which in 1910 became the National Collegiate Athletic Association (NCAA) [25]. Concurrent to these changes came efforts in the medical community to advance the understanding of concussion and its sequelae.
In 1924, Cassasa reported on five autopsies demonstrating “multiple traumatic cerebral hemorrhages” [26]. He correlated these injuries with concussion, and postulated that the mechanism was related to laceration of vessels due to changes in pressure of cerebrospinal fluid throughout the perivascular and perineuronal spaces of the brain [26]. In 1927, Osnato and Giliberti presented “Postconcussion Neurosis-Traumatic Encephalitis” and concluded that with advances in anatomic and pathologic understanding, an updated definition of the term “concussion” was overdue. Like Cassasa, they attributed the signs and symptoms seen in “traumatic encephalitis” to hemorrhages in the perivascular regions of the brain. They went on to state that, “Not only is there actual cerebral injury in cases of concussion, but in a few instances complete resolution does not occur, and there is a strong likelihood that secondary degenerative changes develop.” They also advocated that individuals with long term effects from these injuries be labeled as having “traumatic encephalitis” [27].
The following year, Harrison Martland published “Punch Drunk” in the Journal of American Medical Association (JAMA), detailing the neurocognitive and neurobehavioral condition of 23 professional boxers. Martland attributed the “punch drunk” fighter to “traumatic multiple hemorrhages”, asserting that, “one half of the fighters who have stayed in the game long enough develop this condition, either in a mild form or severe and progressive form which often necessitates commitment to an asylum” [28].
Bowman and Blau first coined the term Chronic Traumatic Encephalopathy (CTE) in 1940 after publishing their examination of a 28-year-old boxer who manifest multiple psychiatric symptoms including paranoia, depression, and “childish behavior” [29]. That individual was initially diagnosed with “Traumatic Encephalopathy” but after his condition did not improve over the course of 18 months the modifier “Chronic” was included, giving rise to the term used today.
Later in the 1940s, Denny-Brown and Russell [30] theorized that the deleterious effects of concussion occurred at the level of the individual neuron. In a 1962 publication of The Lancet, Sir Charles Symonds [31], suggested that, “the instantaneous loss of cerebral function … is due to sudden, direct damage, by stretching or compression, to the nerve cells or fibres of the brain.”
In 1969, Roberts [32] published the first in vivo, clinical examination of traumatic encephalopathy in retired boxers. From an age-stratified random sample of 225 British boxers, he concluded that 17% had CTE, 11% with a mild form and 6% severe. He felt that the syndrome appeared stable over time, with a small subset demonstrating worsening of Parkinsonian symptoms.
In 1973, Corsellis et al. [1] published the first neuropathologic criteria for diagnosing CTE. In an article titled, “The Aftermath of Boxing”, four hallmark neuropathological features were established by consensus after autopsy of 15 boxers. Roberts et al. [33] later re-examined these brains using improved immuno-histochemistry techniques and found that nearly all boxers had amyloid-β deposition consistent with what might be seen in Alzheimer’s disease (AD).
In 1974, neurosurgeons Ommaya and Gennarelli [34] published their work on primates subjected to concussive forces and concluded that concussion was due to diffuse axonal injury. The next 20 years saw an increase in the neuropsychological influence on the field of concussion. Pioneered by Harvey Levin [35] and Jeff Barth [36], and refined by many others including Mark Lovell, neuropsychological testing provided an additional view into the impact and complexity of concussion. In 1984, Casson et al. [37] published a study of brain damage in boxers using EEG, head CT, and neuropsychological testing. Thirteen years later in 1997, Jordan et al. [38] published their findings on the interactive nature of the apolipoprotein Eɛ4 gene and boxing exposure and the later development of chronic traumatic brain injury.
Omalu and colleagues [39] published reports of CTE in former NFL players in 2005 [39], 2006 [40], and 2010 [41], and one former wrestler in 2010 [42]. In 2007, Boston University partnered with the Sports Legacy Institute (now known as the Concussion Legacy Foundation) to create the Boston University Center for the Study of Traumatic Encephalopathy (BU-CSTE), a group that has been on the frontlines of the current CTE debate [43]. Led by Dr. Ann McKee, the BU-CSTE published their first case series of CTE in 2009, [43] along with multiple subsequent CTE-related publications.
DEFINITIONS OF CTE AND NEURODEGENERATIVE DISEASES
Since its inception in 1928, many different definitions of CTE have been published. Generally, CTE is characterized by p-tau accumulation in specific brain locations, and is associated with multiple neuropsychiatric signs and symptoms. Several authors have pointed out the complexity of diagnosing CTE, given the “classic” [1] versus “modern” [44] descriptions, lack of antemortem clinical criteria, and coexisting neurodegenerative diseases [45–48]. Prior to understanding the literature on CTE in sports, we must first define this clinical entity and similar neurodegenerative disorders.
What is a tauopathy?
Tau is a protein that fortifies microtubules in neurons and exists in all individuals. Tau is modified after translation in several ways such as glycosylation, nitration, and truncation, but one post-translation moderation important in neurodegeneration is hyperphosphorylation of tau. Hyperphosphorylated tau, known as p-tau, is associated with several disorders known as tauopathies, including AD, frontotemporal dementia, Parkinson’s disease (PD), progressive supranuclear palsy (PSP), corticobasal degeneration, multiple system atrophy, and others [49]. While the finding of p-tau can be pathologic, it is also present in normal aging. Braak et al. [50] reported that only 10 of 2,332 consecutively autopsied brains (0.004%) were absent of any abnormal tau, and all were under the age of 30 years. The NINDS CTE Neuropathology Consensus group [44] identified p-tau in a specific region and pattern to diagnose CTE, and stated that the p-tau of CTE was different from the age-related tau astrogliopathy or primary age-related tauopathy, previously noted by Braak et al. [50] Overall, due to their relative rarity, these tauopathies are often grouped together as a single endpoint to predict the occurrence of neurodegenerative diseases. The overlap between these tauopathies is an active area of research, and describing discrete differences between each tauopathy remains elusive.
Classic CTE
A recent systematic review of CTE by Gardner et al. [45] proposed two distinct variants of CTE to be described: “classic” and “modern” CTE. This proposal came after the authors concluded distinct clinicopathological differences between the earlier accounts of CTE compared to CTE mentioned over the last two decades. Compared to “classic” CTE, “modern” CTE includes a wider range of clinical symptoms and only one, but more specific neuropathologic finding, mostly seen in former athletes.
While “classic” CTE encompasses almost 80 years of research, it can be boiled down to the work by Roberts et al. [32] in 1969 and Corsellis et al. [1] in 1973. As mentioned above, Roberts evaluated 250 retired boxers in the United Kingdom and reported that central nervous system disorders were present in 17% of cases. Though 37 cases were reported, clinical and pathologic details were included in only 11, and a limited description of each was provided.
Four years later, Corsellis et al. published the first neuropathologic criteria for diagnosing CTE based on autopsies in 15 boxers. These criteria included cerebral atrophy, enlarged lateral/third ventricles, thinning of the corpus collosum, a cavum septum pellucidum with fenestrations, cerebellar scarring, and agyrophilic neurofibrillary degeneration. The specimens used by Corsellis were later reexamined by Roberts et al. [33] who found that nearly all had amyloid-β deposition, suggesting the possibility of AD. Gardner and colleagues continued to note that “classic” CTE does not represent a progressive disease with worsening stages [45]. Moreover, the early descriptions of “classic” CTE were limited by a lack of control for confounding variables, including psychiatric illness, family history variables, substance abuse, or genetic risk factors, limiting the generalizability of their findings.
Early modern definitions of CTE
In 2009, the first contemporary CTE staging system was proposed by McKee and colleagues based on autopsies of 85 individuals with repetitive mild traumatic brain injury (mTBI), 68 (80%) of whom were found to have CTE [43]. Microscopic examinations were performed by a single, blinded neuropathologist— McKee herself— and confirmed by two additional Boston University (BU) colleagues, Dr. Thor D. Stein and Dr. Victor E. Alvarez. The preliminary CTE definition used before the study began included: 1) perivascular foci of p-tau immunoreactive neurofibrillary tangles (NFTs) and astrocytic tangles (ATs); 2) irregular cortical distribution of p-tau immunoreactive NFTs and ATs at the depth of cerebral sulci; 3) clusters of subpial and periventricular NFTs in the cerebral cortex, diencephalon, basal ganglia, and brainstem; and 4) NFTs in the cerebral cortex preferentially in the superficial layers. After the study results, McKee and colleagues proposed four neuropathologic CTE Stages I-IV. An attempt was also made to match clinical symptoms with neuropathologic findings, with corresponding Stages I-IV representing worsening symptoms.
In 2011, Omalu et al. [9] described a distinctly different set of CTE guidelines from McKee’s, which included four phenotypes of CTE based on 17 autopsy findings— 8 professional football players, 4 wrestlers, 1 mixed martial arts fighter, 3 high school football players, and 1 boxer. Unlike McKee’s classification system, each phenotype was not meant to be an advanced form of the prior, and no clinical sign or symptom criteria were mentioned.
Current NINDS CTE neuropathology consensus guidelines
In 2013, the NIH and NFL funded an effort to define the pathological criteria of CTE and long-term outcomes of TBI, which in 2016 produced the first published consensus guidelines of CTE. At the outset, the primary objective was to determine whether CTE was a distinctive tauopathy that could be reliably distinguished from other tauopathies. A total of 25 cases of various tauopathies were selected by four neuropathologists not involved in grading: two from the BU group, one from the Mayo Clinic Jacksonville, and one from Mt. Sinai. A total of 7 neuropathologists experienced in neurodegenerative diseases participated in specimen examinations, including faculty from Washington University School of Medicine, Mayo Clinic Jacksonville, Brigham and Women’s Hospital, University of Washington School of Medicine, Uniformed Services University of Health Sciences, Boston University, and Columbia University. The neuropathologists rated each specimen as 1-unsure, 2-possible, 3-probably, or 4-definite after gross inspection. After initial evaluations, evaluators were then sent gross findings and clinical summaries for each case, and asked to reevaluate the diagnosis and provide a second level of conviction.
The expert panel produced an agreed upon neuropathologic definition of CTE that included: “pathognomonic lesion consist of p-tau aggregates in neurons, astrocytes, and cell processes around small vessels in an irregular pattern at the depths of the cortical sulci.” Several supportive neuropathological features of CTE were also included, along with mention of age-related p-tau astrogliopathy that may be present, which were non-diagnostic and non-supportive of a CTE diagnosis.
When assessing agreement for any tauopathy in the 25 cases presented at the consensus conference, the agreement level was 67%. When assessing agreement for a diagnosis of CTE specifically, the agreement level was 78%, meaning that 22% disagreed on a CTE diagnosis. Among non-CTE cases, more agreement was seen for AD, corticobasal degeneration, and primary age-related tauopathy, yet frequent discrepancies were seen with PSP and argyrophilic grain disease. When a clinical history and pathologic summary were provided, the degree of certainty rose from 3.1 to 3.7, meaning the clinical context made the evaluators more certain of the diagnosis. Comparing these inter-rater agreement values for CTE to AD, a 1997 study by Nagy et al. [51] evaluated a method to diagnose AD based on the sequential accumulation of NFTs in the cortex, without taking into account age, and reported a kappa of 0.90 among 41 brains. A similar study of AD by the same authors assessed the reliability of AD staging in thin paraffin sections and reported kappa values ranging from 0.6–0.8 for both the interrater and the intrarater reliability. Interestingly, a larger study concluded that absolute agreement was 91% when NFTs were substantial, but dropped to 50% in early stages of AD [52].
CTE IN OTHER CONTACT SPORT ATHLETES
Studies investigating CTE in non-football sports have been limited to single case reports or part of a larger series, often predominantly involving football [53]. The description of CTE in soccer, rugby, hockey, and other contact sports has been underrepresented yet is growing. Below, a review of non-football sport participation and long-term neuropathological, structural, and psychosocial outcomes is provided [45].
Soccer
The first identified case of cytoskeletal and pathological changes observed in a former amateur soccer player was presented by Geddes et al. [54], who identified pathological findings of neocortical NFTs and neuropil threads in the absence of amyloid-β protein. This finding occurred in 1999, prior to the consensus criteria established in 2016, thus the degree of accordance with the current pathological criteria (p-tau in sulcal depths) is unknown. Personal or medical histories were not provided for this case. Additionally, this athlete suffered a subdural hematoma resulting in death, which also influenced the neuropathologic findings and decreased the generalizability of the findings.
In the 2014 case series entitled “The Neuropathology of Sport,” McKee and colleagues [55] reported a single case of CTE identified in a 29-year-old semi-professional soccer player without a history of CTE. The athlete was diagnosed with amyotrophic lateral sclerosis (ALS) three months after initially presenting with fatigue and lower extremity/hand weakness at the age of 27 and died of respiratory insufficiency 21 months after diagnosis. CTE stage II with motor neuron disease was identified postmortem, though many of the pathological findings were consistent with changes seen in ALS (degeneration of the anterior horn cells).
The largest, non-football study of CTE involved 6 retired, male soccer players with dementia who were followed between 1980 and 2010 [56]. Of these six cases selected based on an a-priori criteria of cognitive decline (inclusion criteria of dementia), CTE pathology according to the latest consensus criteria was confirmed in four patients [44]. Across the six cases, clinical presentation varied widely and included mood/anxiety, gait/motor, and behavioral changes, with memory impairment recorded as the most prevalent. Similar to many of the studies highlighted above, limitations were inherent in the means of clinical data collection, as the authors relied solely on retrospectively collected collateral history obtained through relatives and medical records. Furthermore, the criteria used to determine behavioral, mood, and cognitive changes were not well-defined or provided. While repetitive head impacts were highlighted as the basis for the observed neuropathology in the series (all were described as “skilled headers of the ball”), findings regarding history of head injury were mixed. Two athletes independently sustained head-to-head collisions during play that resulted in loss of consciousness, and CTE was found in one of these athletes but not the other. Additionally, no CTE was found in a player who also participated in amateur boxing. Interestingly, all six cases exhibited AD pathology and aspects of age-related tau astrogliopathy. Further parallel pathology observed across the six cases included TDP-43 (n = 5/6), cerebral amyloid angiopathy (n = 5/6), hippocampal sclerosis (N = 2/6), corticobasal degeneration (N = 1), dementia with Lewy bodies (n = 1/6), and vascular pathology (n = 1/6). No “pure CTE” was seen. The various concomitant neuropathology combined with less than ideal clinical history collection further cloud interpretation of these findings.
The studies of CTE in soccer are sparse, but more common are studies that assess the impact of heading on long-term neurologic function. Several studies have failed to demonstrate a significant relationship between frequency of heading the ball and adverse cognitive sequelae across a range of time and developmental periods [57–63]. While most systematic or meta-analytic reviews have concluded that no evidence currently exists to suggest a relationship between heading and cognitive impairment, [64–66] the studies that reported a positive relationship were older, taken at a time when the sport used a heavier leather ball prone to water absorption, and included athletes with a history of alcohol abuse [67–70]. A recent systematic review by Tarnutzer and colleagues [71] concluded that the majority of studies reporting persistent impairment from heading were less likely to control for Type I error and select an appropriate control sample when compared with studies showing no impairment. Studies demonstrating an association between heading and cognitive deficits were also more likely to have lower quality methods of assessing and quantifying heading (e.g., retrospective query) than studies reporting no such correlation.
Rugby
Similar to soccer, the association between CTE pathology and rugby has been limited to case series [53]. In the aforementioned study by McKee and colleagues [55], a 77-year-old former rugby player presented with stage IV CTE and dementia. The athlete began playing rugby at the age of 13 years and played for 19 years; level of play was not mentioned. Macroscopic changes associated with severe atrophy and widespread p-tau immunoreactive neurofibrillary pathology and neuronal loss in diffuse cortical and subcortical areas was reported, yet histological staining for other neuropathology was not included. The athlete first exhibited cognitive difficulties in his mid-50s, including memory loss, executive dysfunction, and attention difficulties. This was reportedly followed by depression and anxiety, as well as behavioral changes of explosivity and impulsivity that reportedly progressed to physical/verbal abuse and paranoia by his mid-60s. The method in which these data were collected was not reported, nor was information regarding premorbid mood and behavioral problems, prior head injuries, family history, and substance abuse.
To date, a single pathologically confirmed comprehensive report of CTE in a former professional rugby player was provided by Stewart and colleagues [72]. The individual reportedly possessed a number of vascular risk factors, asthma, alcohol abuse, and “countless head injuries” as reported by family. No psychiatric history was provided. Onset of cognitive difficulties in attention, organization, and memory started at the age of 51 with positive neurological exam findings, including axial rigidity, asymmetrical upper limb rigidity, bradykinesia and ideomotor apraxia. Age-related white matter changes were noted on the MRI scan and a PET-scan revealed reduced accumulation of dopamine isotope in the caudate and putamen nuclei bilaterally, as well as evidence of frontal and posterior cingulate hypometabolism. Following death at the age of 57, widespread p-tau pathologies were recorded throughout the neocortex, hippocampus, and striatum. These findings were greatest in perivascular, subpial, and sulcal depth locations. An antemortem clinical diagnosis of PSP had been made, while postmortem pathological findings included classical Lewy bodies, PSP-like globose tangles, amyloid-related pathologies, and CTE pathology. Though the comorbidity of PSP does obscure the interpretation of clinicopathological interpretation, a strength of this case report is the inclusion of a comprehensive history and findings from clinical examination.
Studies of long-term outcomes in former rugby participation have been generally equivocal. In a retrospective study of 52 retired male Scottish international rugby players between the ages of 26 and 79 years (mean = 53.5) and 29 age-matched controls, McMillan et al. [73] failed to demonstrate significant differences in various health conditions, social or work functioning, and self-reported measures of mental health, which fell within the “normal range.” The retired rugby athlete group did exhibit poorer performance on a metric of verbal learning (Rey Auditory Verbal Learning Test) and dominant hand fine motor dexterity; however, there was no correlation between frequency of concussion (mean = 13.9) and cognitive functioning.
A second cross-sectional study examined long-term outcomes in 259 former elite, male rugby players (mean age = 60.1 + 16.1), as compared to population-based standardized morbidity rates (SMR) based on multiple population-based health-related surveys [74]. Former elite rugby athletes who averaged 22 years of sport exhibited similar long-term rates of dementia and depression following retirement compared to population-based SMR. A fair criticism of the study, as acknowledged by the authors, was the significant difference in age of the population-based reference group (older on average). However, these outcomes remained the same when controlling for age. In the same study, former elite rugby players were two times more likely to experience anxiety. Interestingly, 85% of former rugby athletes did not endorse experiencing anxiety and depression on a separate health-related quality of life instrument (EQ-5D-5L). The authors of the study attributed these mixed results to the timeframe of symptoms solicited; the significant findings asked questions of lifetime prevalence, whereas the non-significant findings asked about current symptomatology. Regardless, SMR were significantly higher in former elite rugby players, which raises suspicion. As part of the study, there was no discussion of CTE or neurodegenerative diagnoses other than “dementia.”
Regarding structural brain changes, Wojtowicz and colleagues [75] examined cortical and frontal thickness, as well as subcortical brain volumes in 24 relatively young (mean = 33.3 years-old), active, and retired professional rugby athletes, as compared to age- and education-matched controls. No between-group differences in psychiatric symptoms (depression and anxiety), cognitive functioning across a number of domains (with the exception of a single visual memory-related metric), or whole brain cortical and frontal lobe thickness were seen. Although rugby athletes did exhibit smaller bilateral hippocampi and left amygdala, follow-up analysis suggested that differences in subcortical nuclei volumes were likely attributable to alcohol use, especially in the rugby group.
Ice hockey
As part of a larger case series of individuals reportedly exposed to repetitive head mTBI [76], eight former hockey players (5 professional, 2 college/amateur, and 1 high school) were examined for CTE pathology. Of the eight, three were identified as exhibiting no CTE-related pathology and three were classified as possessing early disease stage pathology (Stage II). Of the two exhibiting more “progressed” pathology consistent with later stages of the disease (stage III and IV), both possessed multiple concomitant neuropathologies (e.g., diffuse amyloid-β, alpha synuclein, and neuritic amyloid-β plaques) and parallel neurodegenerative diagnoses (AD and Lewy body dementia (LBD)). Similar to the previously discussed soccer players, the concomitant pathology clouds interpretation of the relationship between hockey exposure and adverse outcomes. Furthermore, clinicopathological correlations (behavioral, cognitive, mood changes) of the former hockey players were not reported. This relationship between neuropathology and clinicopathological correlations is further confounded by the absence of CTE pathology during a recent autopsy of a 49-year-old retired professional hockey player who suffered from symptoms/conditions commonly said to be associated with CTE (i.e., self-reported memory loss, depression, and suicide) [77].
Investigations into long-term outcomes associated with participation in elite hockey have been limited. Esopenko et al. [78] examined cognitive and psychosocial functioning in 33 retired professional hockey players, with additional consideration of concussion exposure and genetic (apolipoprotein ɛ4) influence. Results revealed no significant group differences across a wide array of cognitive functions (i.e., attention, verbal memory, visuospatial functioning, inhibitory control, and reaction time). Group differences were observed on select measures of psychosocial factors comprised of multiple psychiatric and behavioral inventories, executive function and visual reasoning, with a significant association between greater concussion history and lower cognitive performance on these measures. Increased psychosocial disturbances were associated with the presence of the apolipoprotein ɛ4 allele. The degree to which differences were observed and further examination into how specific inventories differed was not performed.
Other limited-contact sports
The study of CTE in other common sports, such as baseball and basketball, is even more limited. A study of 66 individuals with sport exposure from a neurodegenerative disorder brain bank revealed the presence of Stage II CTE in a single former semi-pro baseball athlete. No information on baseball head impacts was provided [79]. AD-like (amyloid-β) pathology was also identified in this 87-year-old former semi-professional baseball. No antemortem cognitive or functional impairment was demonstrated at any point. CTE pathology was not observed in six other former baseball athletes (2 semi-professional, 1 college, and 3 high school level) with various other positive neuropathological findings in this sample. A single former high school basketball athlete was also identified in the sample as possessing stage I CTE, along with co-occurring ALS pathology. This is consistent with the established overlap of CTE and ALS pathology [75, 81]. Concussion history for the sample was not reported and both the former baseball and basketball athletes had a positive history of reported alcohol use, of which the degree of consumption was unknown.
In conclusion, of the few larger series of case studies, CTE has been identified postmortem in a select number of non-football cases. CTE in non-football athletes was significantly obscured by confounding neurodegenerative disorders, the presence of neuropathology in athletes who were asymptomatic at death, and methodological flaws, such as not controlling for long-standing medical conditions and poor sampling/data recording techniques (e.g., remote retrospective query of behaviors and cognitive functioning rather than objective measures). Findings demonstrating adverse long-term cognitive, behavioral, and emotional outcomes in non-football sports have been mixed, with better-designed studies much less likely to demonstrate negative outcomes.
CTE IN AMERICAN FOOTBALL ATHLETES
Studies of CTE in football players
The earliest CTE study by the BU group was published in 2009 [43], where 5/51 (10%) of all CTE positive athletes were football players, and the remaining 46 were boxers. All 5 football players died in middle age (36–50 years) and played broadly similar positions (3 offensive linemen, 1 defensive lineman, 1 linebacker). Concussion information was obtained from next of kin and often included non-medically confirmed concussion history data. For example, one player’s wife reported 8 NFL concussions, though only one was medically confirmed. Most common was a diagnosed mood disorder (depression), along with memory loss, paranoia, poor judgment, anger, irritability, apathy, confusion, and poor concentration. Cause of death was reported for 4 of 5 football players and included suicide (2), high-speed police chase resulting in motor vehicle collision, and accidental gunshot wound. The authors concluded that there was “overwhelming evidence” that CTE was the result of repeated sub-lethal brain trauma that often occurred well before the development of clinical manifestations [43]. The authors also mentioned that pathologically, CTE shared features with AD, and that the Aβ and NFTs found in CTE are immunocytochemically identical to those found in AD, suggesting a possible common pathogenesis [43].
Four years later, a second study from the BU group reported on brain autopsies of 85 individuals with repetitive mild head impacts. In this sample, 68 (80%) tested positive for CTE based on the presence of p-tau [76]. Of the 68 CTE positive players, 50 played football— 35 professionally, 9 college, and 6 high school. The breakdown of CTE stage for the 35 football players included: 3 Stage I, 3 Stage II, 9 Stage III, and 7 Stage IV, with the remaining 11 having concomitant pathology and one player with no disease. Thirty-one of the 34 former professional football players had stage III–IV CTE or CTE plus co-morbid disease (89%). Positions played by NFL players positive for CTE included offensive linemen (26%), running backs (20%), defensive linemen (14%), linebackers (14%), quarterbacks (6%), defensive backs (6%), tight ends (6%), and wide receivers (6%). The authors concluded a positive correlation between years of football played and stage of CTE; yet number of concussions, years of education, and lifetime steroid use, all obtained secondarily from family, were not significantly associated with CTE stage. Moreover, none of the secondary analyses controlled for confounding variables, such as learning disorder, attention-deficit hyperactivity disorder, family history of neurocognitive disorders, or alcohol/substance abuse. Importantly, 17/50 had concomitant neurodegenerative diseases (AD, LBD, frontotemporal lobar degeneration, motor neurone disease, Pick’s disease, and PSP). The authors concluded that repetitive TBI “might trigger molecular pathways that result in the overproduction and aggregation of other proteins prone to pathological accumulation in neurodegenerative disease such as those listed above,” yet no justification was provided. The authors also cited literature showing that trauma was a risk factor for dementia, AD, ALS, and PD, yet these studies defined head injury as a hospitalized, closed head injury suffered during World War II, [82] lifetime head injury resulting in loss of consciousness and hospitalization, [83, 84] and one study assessed any traumatic incident, where only 7% (76/1131 participants) were concussions [85]. Perhaps most important, the study by Plassman et al. [82] of World War II veterans showed that mild TBI, irrespective of APOE ɛ4 allele status, was not a risk factor for dementia. Overall, these preliminary reports of CTE are exploratory in nature, and causal associations prove difficult to conclude given their nature as convenience samples, data collection methods, and comorbid pathologies.
In 2011, Omalu and colleagues [9] reported that 10 of 14 (71%) of professional male athletes (ages 18–52) were positive for CTE, including 7 of 8 professional football players and 1 of 3 high school football players. The single professional football player who tested negative for CTE was 24 years old. All three high school footballers died of acute brain and spine injuries suffered while playing. Importantly, the coexistence of severe TBI that resulted in these deaths has the potential to markedly affect pathological examination of these brains and diminish generalizability. No NFTs or neuropil threads (NTs) were identified in the 16- and 17-year-olds, but very sparse (1 to several) NFTs and NTs were seen in the cerebral cortex, subcortical nuclei/basal ganglia, hippocampus, and brainstem of the 18-year-old, which was interpreted as “incipient” CTE (abnormal tau protein). This individual had been playing football for approximately 6 years, but no other biopsychosocial or demographic information was provided. Though not separated into football players only, the authors noted that alcohol- and drug-related deaths were overrepresented in the CTE cohort, and AD-type atrophy was absent in all cases. The authors also cautioned against diagnosing CTE in the elderly (>65 years) to avoid confusing CTE changes with AD, normal aging, and chronic ischemic changes due to small vessel disease, in addition to the fact that amyloid may be found in cognitive normal elderly individuals [86]. Interestingly, the authors concluded by postulating four emerging and recurring histomorphologic CTE phenotypes based on the presence or absence of NFTs, NTs, and diffuse amyloid plaques in the cerebral cortex, subcortical nuclei/basal ganglia, hippocampus, and cerebellum, as well as the topographic distribution and predominance of NFTs, NTs, and amyloid plaques in those locations [9]. As stated above, this description of CTE differed from that proposed by McKee in 2013 [76] and the subsequent NINDS classification [44]. Omalu [9] did not find accumulation of tau-immunoreactive astrocytes, and the authors proposed that this difference may be due to difference in sport played (boxing versus football).
In 2013, Hazarati et al. [87] reported on a convenience sample of six retired Canadian Football League players, all of whom manifested progressive neurodegeneration prior to death. Three of 6 (50%) tested positive for CTE, while the remaining three were diagnosed with AD, ALS, and PD, respectively. The 3 CTE positive cases had comorbid pathology indicative of cancer, AD, and vascular disease. The authors concluded that the comorbid pathological findings may have contributed to the neurologic decline and that caution should be utilized in the diagnosis of CTE when other neurodegenerative diseases are present. The study by Hazrati and colleagues supports the notion that not all athletes with a history of repetitive head trauma developed CTE, and CTE alone is not responsible for any neurologic decline.
The largest study of football players and CTE was published in 2017 by Mez and colleagues [2] and was the most read article of JAMA in 2017 [88]. In a study of 202 former football players whose next of kin voluntarily donated their brains to the BU brain bank, 177 brains (87%) were positive for CTE, including 0/2 pre-high school, 3/14 high school (21%), 48/53 college (91%), 9/14 semi-professional (64%), 7/8 CFL (88%), and 110/111 NFL (99%) players. The diagnosis of CTE was divided into two principle categories, each made up of two stages: Mild CTE (n = 44), including Stage I (1 or 2 lesions) and Stage II (3 or more lesions). Severe CTE (n = 133) included Stage III (“multiple” lesions) and Stage IV (“densely distributed” lesions). The authors acknowledged their convenience sample of deceased football players, and postulated that it was unclear whether concussions or subconcussive impacts were responsible for the high proportion of CTE.
Several aspects of the study limit interpretation of the findings. First, ascertainment bias (families of players voluntarily donated their brains to comprise the study population) resulted in a biased sample that inaccurately estimates the prevalence of CTE. Quite accurately, the authors mentioned that 99% of this convenience sample of former NFL players had CTE. However, the conclusion was apparently misinterpreted by media outlets as, “99% of NFL players had CTE.” Second, all NFL concussion and cognitive data were collected through family and next of kin on a postmortem basis. Recall bias has been shown to affect an individual athlete’s ability to recall head injury information at the youth level, let alone in retired athletes [89]. Asking family members about the careers of retired players that took place 20–30 years prior may falsely represent specific facts about one’s football playing career, as well as the onset, degree, and progression of clinical presentation/symptoms. Third, the study population from the BU brain bank was not representative of the American football population, limiting generalizability of the results. Fourth, substance use disorders were noted in 2/3 of the study population with mild or severe CTE. Not only can substance use cause neurologic injury and decline, but opiate abuse can also cause abnormal p-tau deposition, [90–92] and opiate abuse has been noted to be common among NFL retirees [93]. Fifth, whereas previous studies have utilized comparison groups with good control selection, no such comparison of all individuals exposed to football was present.
Sixth, and perhaps most important, the minimum threshold for CTE diagnosis consisted of a single p-tau lesion at the depths of a sulcus in the cerebral cortex, reportedly distinct from the lesions of aging-related tau astrogliopathy. Although this criterion is the solitary one postulated by the 2016 consensus criteria for a neuropathologic diagnosis of CTE, this low threshold maximizes sensitivity at the cost of specificity [94–96]. Whereas known neuropathologic diagnoses such as AD and LBD require many lesions to be present per a certain area, no such criteria exists for CTE. Moreover, in the Severe CTE group, accumulations of amyloid-β, a-synuclein, and TDP-43 were common, in addition to other comorbid neurodegenerative diseases, including AD, LBD, or frontotemporal dementia. It is possible that the p-tau seen were associated with these comorbid neuropathologies, and not CTE.
Reviews
Three systematic reviews on CTE in sports have been published; two exclusively on CTE in sports [45, 97]. Though many excellent narrative reviews have been published, for the purposes of this chapter, only systematic reviews will be discussed.
In 2014, Gardner, Iverson, and McCrory summarized the 85 cases of CTE published to date, [9, 76] drawing from 158 autopsy cases examined for CTE. First, the authors described the previously mentioned dichotomy of older, ‘classic’ description of CTE, which differed significantly from the ‘modern’ syndrome in the age of onset, natural history, clinical symptoms, and pathologic diagnostic criteria. The specific characteristics of modern CTE appeared to be the location of the neuropathology, in the gray matter and perivascular space at the depths of sulci, rather than the specific protein or lesion type [45]. Of the 85 cases of autopsies that have been performed in athletes over the past 10 years, 20% had ‘pure’ neuropathology consistent with CTE only, 52% had CTE plus other neuropathology, and 29% had no neuropathology or other neuropathology. The authors concluded that the strongly held causal assumptions relating to concussive and subconcussive brain impact exposure derived from the case studies were, “scientifically premature,” especially given the absence of cross-sectional, epidemiological, prospective studies on the topic [45]. Furthermore, they summarized five important methodologic concerns when interpreting this literature: 1) the neuropathologic impact of drug/steroid abuse, alcohol abuse, psychiatric problems, cardiovascular/cerebrovascular disease is unknown; 2) the degree to which neuropathologic findings contribute to the clinical features witnessed; 3) genetic assessment of these individuals remains incomplete; 4) moderating and confounding variables between neuropathologic findings and neurologic symptoms are not known; and 5) a denominator of those at risk for CTE to accurately assess prevalence has not been adequately determined.
The second systematic review of CTE was conducted by Maroon and colleagues [97], which included a total of 153 neuropathologically confirmed cases of CTE in contact sports, 63 of which were football players. Of the 63 football players, substance abuse was seen in 9 players (14%). The authors concluded that the true incidence of CTE is unknown due to inconsistent definitions, a lack of longitudinal studies, and significant overlapping symptoms with common neurodegenerative disease. Furthermore, while McKee et al. [76] postulated that pathological findings in CTE were correlated with the numbers of years of football, three of seven high school football players in their review had CTE prior to the age of 20. It was also noted that a lower proportion of substance abuse was seen in football players compared to non-football players (14% versus 21%); however, the impact of substance abuse, namely opioid abuse in former NFL players, could not be determined as many studies did not assess these data points. The authors concluded that given the many limitations in the literature, conclusions regarding the prevalence of CTE among football and other contact sports cannot yet be determined.
Lastly, as part of the 2016 Concussion In Sport Group meeting in Berlin, Manley and colleagues [48] produced a comprehensive systematic review on potential long-term effects of SRC, of which CTE was discussed extensively. The authors correctly mentioned that prior to 2015, no agreed upon neuropathological criteria existed for identifying CTE, [44] and that the new consensus criteria excludes tauopathies associated with aging, such as age-related tauopathy [98] and age-related tau astrogliopathy [99]. Furthermore, tauopathy, amyloid-β, alpha-synuclein, and TDP-43 positive immunoreactivity occurs with normal aging, other neurodegenerative diseases, and in those with normal cognition [100]. After the exhaustive review, the international experts concluded, “A cause and effect relationship between CTE and concussions or exposure to contact sports has not been established,” and additional case-control, cohort, and longitudinal studies are needed to understand the incidence, prevalence, extent to which the neuropathological findings cause specific clinical symptoms, the progressive nature of the disease, clinical diagnostic criteria, and other risk or protective factors.
Epidemiological studies
Though professional football players have been well studied, these elite athletes are not representative of the general population. Several epidemiologic investigations of high school football players and the subsequent development of neurodegenerative disorders have yielded important results, the most notable of which will be discussed here [79, 101–103].
In the largest population-based neuropathologic study with an outcome of pathologically confirmed CTE, Bieniek et al. [79] reported brain autopsy findings in 66 former athletes. In these former athletes, 21/66 (32%) had CTE, and only 1/66 (5%) had “pure” CTE, whereas the remaining 20 displayed mixed neuropathology with concomitant neurodegenerative diseases. Taken from the Mayo Clinic brain bank in Jacksonville, FL, inclusion criteria were presence of paraffin-embedded tissue, at least minimal medical documentation, and male sex, and subjects were excluded if they had a known neuropathologic diagnosis of PSP, corticobasal degeneration, Pick’s disease, and a mutation in the microtubule associated protein tau gene (MAPT). Of note, cases of comorbid dementia, AD, or LBD were not excluded. Of the 1721 male remaining cases, 66 had a history of exposure to contact sports, and controls were men without documented exposure to contact sport. Within the contact sport exposure group, a total of 21/66 individuals (32%) tested positive for CTE, with 7 cases were classified as CTE Stage I, 7 CTE Stage II, 5 CTE Stage III, and 2 CTE Stage IV. Of the 43 patients with exposure to contact sports through football (football only and multiple sports), 16 (37%) had CTE pathology. Of these, 6 played up to high school level, 7 played to college, and 1 played professional football. In the 27 former football players without evidence of CTE pathology, 15 played up to the high school, 7 played up to college, and none played professional football. There were no significant differences in the proportion of football players with CTE pathology with respect to level of involvement (high school, college, professional; p = 0.175). On the 198 disease- and age-matched controls, no CTE pathology was seen, even in 33 controls with documented head trauma not related to contact spots. In terms of comorbid pathology, 20 of 21 (95%) confirmed CTE diagnoses met criteria for other neurodegenerative conditions. Overall, this study is important in that it serves as one of the few large scale, epidemiologic efforts to assess the prevalence of CTE. It should be noted that the rate of contact sports was exceedingly low, at 66/1721 (3.8%) male subjects, which raises concerns regarding the representativeness of the sample and results. A 2010 report concluded that more than 7.6 million students played high school sports, approximately 55.5% of all high school students [104]. Though the generalizability of these results is greater than the aforementioned studies of elite football players and athletes, the sample for the study was derived from brain bank predominantly dedicated to the collection of brains diagnosed with neurodegenerative disorders in the living, and in mostly Caucasians living in the Southeastern U.S. Furthermore, any descriptive assessment of head trauma or presentation/symptoms in the affected individuals could not be evaluated, creating ambiguity regarding the clinical meaningfulness of pathological findings.
In a study of high school football players from Rochester, MN from 1946–1956, Savica et al. [102] compared football players to a control group comprised of male students in the band, glee club, or choir. Using the records-linkage system of the Rochester Epidemiology Project from 2010-2011, the authors recorded later development of dementia, PD, or ALS and compared disease frequencies to the general population of Olmsted County, MN. The authors reported no increased risk of dementia, PD, or ALS among the 438 football players compared with the 140 non-football-playing male classmates. Compared to the general population, only PD was significantly increased; however, this was true for both groups, with a 2.4x greater risk for the football playing group and 5x greater for controls. Five years later, a follow-up study over a 40-year time period by Janssen et al. [101] of 296 high school football players compared to 90 swimmers, wrestlers, and basketball players from 1956–1970, assessing for the presence of dementia/mild cognitive impairment, ALS, and PD. The results indicated that varsity high school football players did not have an increased risk of neurodegenerative diseases compared with athletes engaged in other varsity sports.
The third long-term epidemiologic study estimated the association of playing high school football with cognitive impairment and depression at 65 years of age. After exclusions for missing data, Desphande et al. [103] studied 2,692 men, 834 (31%) of whom played football compared to 1,858 (69%) who did not. Two primary outcomes included a measure of cognitive impairment with a composite cognition measure of Letter Fluency and Delayed Word Recall. Depression was measured with the WLS-modified Center for Epidemiological Studies Depression Scale. After an extensive 1:1 matching process of baseline covariates, including adolescent IQ, family background, education level, and three different control conditions (all controls, non-collision sports, and no sports), playing football was not statistically associated with a reduced composite cognition score or increased depression score. Furthermore, after adjustment for multiple statistical tests, playing football did not have a significant adverse association with any of the secondary outcomes, such as the likelihood of heavy alcohol use at 65 years of age. Though other well-known neurodegenerative disorders were studied rather than CTE, which is understandable given its infancy and brain autopsy is the only means of diagnosis, these well done, prospective epidemiologic studies suggest no increased risk of neurodegenerative disorders or clinicopathological symptoms (e.g., cognitive impairment and depression) supposedly associated with CTE among high school football players compared to controls and the general population.
Additional studies
Though not specifically related to CTE or neurodegenerative disorders, four additional studies of American football players deserve mention [13, 105–107]. Baron studied 334 deceased former NFL players from 1959–1988 and concluded the rates of psychiatric illness and suicide were lower for former NFL players compared to the general population, and though the rate of neurodegenerative diseases was slightly higher than the general population (3.6% versus 2.9%), this was not a statistically significant difference. Using the same dataset of 334 deceased NFL players, Lehman et al. [106] found that overall player mortality compared to that of the US population was reduced, but neurodegenerative mortality was increased, including ALS and AD (NFL players were 3 times higher than that of the general US population). Two years later, the authors reported on 537 deceased NFL players and revealed that suicide among NFL players was significantly less than the general population (2.2% versus 4.8%), with no difference between speed and non-speed position players. Further, on the topic of suicide, Webner and Iverson [108] summarized 26 professional football players who committed suicide, with most deaths occurring in the last 15 years. The authors noted that most of the men suffered from multiple life stressors prior to their deaths, including retirement, loss of income, divorce, failed business ventures, family member estrangement, and substance abuse disorders, highlighting the multi-factorial nature of suicide in former NFL athletes.
Most recently in 2018, Venkataramani and colleagues [105] retrospectively studied mortality risk in 2,933 regular NFL players and 879 replacement players, who debuted between 1982–1992. A total of 144 NFL players (4.9%) and 37 replacement players (4.2%) died, and no statistically significant increase in mortality was associated with career players versus replacement players (HR 1.38, 95% CI, 0.95 to 1.99; p = 0.09). Neurodegenerative disorders were responsible for only 7% of deaths in the career players, which ranked 7th behind cardiometabolic (35%), transportation injuries (14%), unintentional injuries (10%), and others. Of note, all 7 deaths were due to ALS, and none due to CTE.
REMAINING QUESTIONS
How common is p-tau?
Recent focus has been directed toward the question of whether p-tau is unique to CTE. Multiple studies have previously demonstrated “CTE-like” p-tau pathology co-morbidly in a number of individuals without a history of head trauma, which include temporal lobe epilepsy [109, 110], ALS [111], the general population [112], and multiple systems atrophy [113]. Ultimately, this creates uncertainty around the specificity of the diagnostic consensus criteria put forth by the NINDS/NIBIB, which includes p-tau aggregates in neurons, astrocytes, and cell processes around small vessels in an irregular pattern at the depths of the cortical sulci [44]. Specificity of the criteria is called into question further based studies that have demonstrated head injury was not an independent predictor of p-tau pathology, when accounting for other comorbid pathologies or processes, such as ALS [80]. This is supported further by Noy et al. [112], who demonstrated that only a combination of head injury and alcohol and/or drug abuse, as well as age, were significant predictors of p-tau pathology in autopsies performed prospectively at a routine neuropathology service.
Lack of sociodemographic information
A crucial feature in studies on CTE to date is the paucity information regarding past psychiatric, socioeconomic, substance use, medical and family histories of the individuals examined. Whereas these demographic factors are routinely controlled in studies of SRC and TBI outcomes, they are largely missing due to the rarity and small samples of CTE studies. It has been empirically established that multiple factors have the potential to impact the development and presentation of CTE. Without rigorously controlling for such crucial biopsychosocial information, including age [114, 115], substance use [90, 117], psychiatric history [115], cardiovascular/cerebrovascular disease, or other health conditions, interpretation of any findings may be seriously compromised. In their systematic review, Maroon et al. [97] noted that very few studies took into account drug and substance use/abuse histories. Furthermore, study populations were homogenous and suffered from low numbers, making it difficult to draw generalizable information applicable to other populations. That said, some studies have made an effort to measure and control for confounding variables. In largest study of CTE to date, substance use disorders, suicidality, and family history of psychiatric illness were seen in 32 (67%), 22 (47%), and 23 (49%) cases, respectively [2]. Outside of this, few reports have considered demographics and comorbidities. Several authors have cautioned against over concluding without consideration of these important modifiers. Iverson and colleagues [46] contrasted CTE to AD, that when low levels of AD neuropathology are seen with major cognitive impairment, it is possible that other comorbid diseases may substantially contribute to the clinical decline.
The importance of comorbid pathology
A common theme among the previously mentioned studies is the concomitant neuropathology that often accompanies a CTE diagnosis, including LBD and AD, among others. In some of the more notable studies, the following rates of comorbid pathology were found: 32 of 111 in Mez et al. [2], 20 of 21 by Bienek et al. [79], and 3 of 3 by Hazrati et al. [87] The review by Gardner and colleagues concluded that 20% of reports had “pure” CTE and 52% had CTE plus other neuropathology. Given the prevalence of comorbid diagnoses, what can we conclude about the high rate of comorbid pathology?
One interpretation is that the relationship between contact sport and neurodegeneration is strengthened by multiple neuropathologic entities seen together. A cascade of neuropathologic abnormalities has been noted, contributing to a neurologic decline and possibly premature death. However, an alternative explanation questions the existence and importance of CTE— is it possible that the p-tau in cortical sulci depths is just an artifact of normal aging and/or part of the other comorbid neuropathologic diseases, and not unique to CTE? The truth remains elusive, but several authors have weighed in. In 2011, Omalu et al. [9] acknowledged the coexistence of CTE and other pathologic findings, and recommended that, “these additional findings be enumerated as separate diagnoses accompanying CTE.” The same authors go on to caution the diagnosis of CTE in those older than 65 years, “to avoid confusing CTE changes with AD pathology, normal age related, changes in the brain, and/or chronic ischemic changes/small vessel disease changes in the brain,” and that NFTs and amyloid plaque, “may be found in low densities … in cognitively normal elderly individuals [9]. Hazrati et al. [87] and Gardner et al. [45] emphasized that the comorbid pathology may have contributed to the clinical signs and symptoms witnessed prior to death, and that differentiation of which pathologic diagnoses was responsible for clinical decline cannot be determined. As with most controversial aspects of CTE, research remains ongoing.
FUTURE DIRECTIONS CTE RESEARCH
Clearly, chronic traumatic encephalopathy has garnered significant scientific and media attention with the publication of numerous studies aiming to demonstrate or disprove a relationship between contact sports and neurodegeneration. Unfortunately, both the public and the scientific community are left unsure how to proceed. Questions regarding the acceptable age of contact sport participation and even whether football can remain a viable athletic venture have been raised. How can and how should the public and scientific community move forward?
In order to expand and enlighten our understanding of CTE, the challenge is reconciling these positive and negative studies while simultaneously separating from an emotional belief that has taken hold in the public’s eye— the now seemingly well-accepted notion that repetitive mild head injury leads to chronic degenerative disease. Allowing oneself to make this leap bypasses the necessary initial questions of scientific research: What are the mechanisms of pathogenesis? What is the prevalence and frequency? Are there specific risk factors? Reconsidering CTE as a novel, underdeveloped neuropathologic entity presents opportunities to truly answer these questions, while viewing CTE as a well-defined entity induced by head injury in a causal manner stymies critical studies to better understand pathogenesis and risk profiles. Simply restating the question, “Do contact sports lead to CTE?” to the broader questions of, “What is the prevalence of diffuse perivascular tauopathy in the general population? and What risk factors exist?” eliminates the emotional, highly charged topic of head injury in sports. This question attempts to hone in on general aspects of the disease, which largely remain unknown as CTE research quickly moved past the early steps of disease study.
For both the public and especially those with the opportunity to add to the literature surrounding CTE, moving forward means taking every opportunity to think critically about one’s own data and other published studies. Critical appraisal can prompt methodological improvement. For example, the majority of autopsy studies [2, 76] are cross-sectional in nature with few participants providing prospective data, while the few longitudinal/long-term follow-up studies [103, 118] do not seem to suggest any differences in in risk for neurodegeneration between contact and non-contact athletes. How do we reconcile this? Does a high proportion of positive autopsies in very well-defined symptomatic samples suggest a high overall prevalence? Critically assessing these studies by asking questions helps to define the critical attributes of an ideal study of CTE.
Based on a thorough critique of the literature, it seems that future studies of CTE should strive to include as many of the following components as possible. First, the study will prospectively collect extensive medical, family and social histories from participants. Additionally, prospective sign, symptom and head injury exposure data collection will improve accuracy and assist in delineating a more precise phenotype of CTE. Recall bias clouds any retrospective collection, especially with retired players, data collection from next of kin, and often in the context of litigation. Second, these data will be collected longitudinally over an extended period (decades), which will help establish the natural history and correlate signs and symptoms to neuropathologic findings if they exist following the methodology of Braak et al.’s landmark work with AD [119–122]. Finally, studies should aim for wide enrollment including a variation in degree of sport participation, head contact propensity and when applicable neuropsychiatric symptoms (from asymptomatic to severely symptomatic). Also of interest would be those with similar neuropsychiatric symptoms but without any history of head trauma. Keeping these key aspects in mind during study development and implementation will lead to studies that move the literature forward and answer key unanswered questions regarding CTE.
